Form Type: 4

SEC EDGAR Link
Accession Number:0000899243-21-021651
Date:2021-06-01
Issuer: GLOBAL BLOOD THERAPEUTICS, INC. (GBT)
Original Submission Date:

Reporting Person:

SMITH-WHITLEY KIM
C/O GLOBAL BLOOD THERAPEUTICS, INC.
181 OYSTER POINT BLVD. SOUTH SAN FRANCISCO, CA 94080

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
RESTRICTED STOCK UNITS 0.0 2021-06-01 deemed execution date A 24,160 (a) common stock 24,160 $0.00 24,160 direct
RESTRICTED STOCK UNITS 0.0 2021-06-01 deemed execution date A 6,300 (a) common stock 6,300 $0.00 6,300 direct
STOCK OPTION (RIGHT TO BUY) 37.2 2021-06-01 deemed execution date A 35,500 (a) 2031-05-31 common stock 35,500 $37.20 35,500 direct
Footnotes
IDfootnote
f1 each restricted stock unit ("rsu") represents the right to receive one share of the issuer's common stock.
f2 the rsus vest with respect to 25% of the underlying shares on june 1, 2022 and in six semi-annual installments thereafter, so long as the reporting person continues as an employee or other service provider of the issuer through each vesting date. the rsus are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the issuer.
f3 the rsus vest in installments conditioned upon the achievement, on or before june 30, 2024, of up to three specified market price thresholds of the issuer, subject to the reporting person's continuous service with the issuer through each vesting date. the rsus are subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the issuer.
f4 the stock option vests with respect to 25% of the underlying shares on may 3, 2022 and in 12 equal quarterly installments thereafter, so long as the reporting person continues as an employee or other service provider of the issuer through each vesting date. this option is subject to accelerated vesting upon termination without cause or resignation for good reason after a change of control of the issuer.

Elevate your investments